Human papillomavirus and cervical cancer M Schiffman, PE Castle, J Jeronimo, AC Rodriguez, S Wacholder The lancet 370 (9590), 890-907, 2007 | 3841 | 2007 |
The Risk of Cancer Associated with Specific Mutations of BRCA1 and BRCA2 among Ashkenazi Jews JP Struewing, P Hartge, S Wacholder, SM Baker, M Berlin, M McAdams, ... New England journal of medicine 336 (20), 1401-1408, 1997 | 2993 | 1997 |
Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly TB Harris, L Ferrucci, RP Tracy, MC Corti, S Wacholder, WH Ettinger Jr, ... The American journal of medicine 106 (5), 506-512, 1999 | 2066 | 1999 |
Assessing the probability that a positive report is false: an approach for molecular epidemiology studies S Wacholder, S Chanock, M Garcia-Closas, L El Ghormli, N Rothman Journal of the National Cancer Institute 96 (6), 434-442, 2004 | 1868 | 2004 |
Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia MH Schiffman, HM Bauer, RN Hoover, AG Glass, DM Cadell, BB Rush, ... JNCI: Journal of the National Cancer Institute 85 (12), 958-964, 1993 | 1838 | 1993 |
A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer DJ Hunter, P Kraft, KB Jacobs, DG Cox, M Yeager, SE Hankinson, ... Nature genetics 39 (7), 870-874, 2007 | 1772 | 2007 |
The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in … MJ Khan, PE Castle, AT Lorincz, S Wacholder, M Sherman, DR Scott, ... Journal of the National cancer Institute 97 (14), 1072-1079, 2005 | 1480 | 2005 |
Genome-wide association study of prostate cancer identifies a second risk locus at 8q24 M Yeager, N Orr, RB Hayes, KB Jacobs, P Kraft, S Wacholder, ... Nature genetics 39 (5), 645-649, 2007 | 1328 | 2007 |
Multiple loci identified in a genome-wide association study of prostate cancer G Thomas, KB Jacobs, M Yeager, P Kraft, S Wacholder, N Orr, K Yu, ... Nature genetics 40 (3), 310-315, 2008 | 1120 | 2008 |
Human papillomavirus testing in the prevention of cervical cancer M Schiffman, N Wentzensen, S Wacholder, W Kinney, JC Gage, ... Journal of the National cancer institute 103 (5), 368-383, 2011 | 1023 | 2011 |
Selection of controls in case-control studies: I. Principles S Wacholder, JK McLaughlin, DT Silverman, JS Mandel American journal of epidemiology 135 (9), 1019-1028, 1992 | 1020 | 1992 |
Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica R Herrero, A Hildesheim, C Bratti, ME Sherman, M Hutchinson, J Morales, ... Journal of the National Cancer Institute 92 (6), 464-474, 2000 | 896 | 2000 |
The relation of risk factors to the development of atherosclerosis in saphenous-vein bypass grafts and the progression of disease in the native circulation: a study 10 years … L Campeau, M Enjalbert, J Lespérance, MG Bourassa, P Kwiterovich Jr, ... New England Journal of Medicine 311 (21), 1329-1332, 1984 | 857 | 1984 |
Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial A Hildesheim, R Herrero, S Wacholder, AC Rodriguez, D Solomon, ... Jama 298 (7), 743-753, 2007 | 820 | 2007 |
Selection of controls in case-control studies: II. Types of controls S Wacholder, DT Silverman, JK McLaughlin, JS Mandel American journal of epidemiology 135 (9), 1029-1041, 1992 | 795 | 1992 |
HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica M Schiffman, R Herrero, A Hildesheim, ME Sherman, M Bratti, ... Jama 283 (1), 87-93, 2000 | 782 | 2000 |
Binomial regression in GLIM: estimating risk ratios and risk differences S WACHOLDER American journal of epidemiology 123 (1), 174-184, 1986 | 775 | 1986 |
Estimation of effect size distribution from genome-wide association studies and implications for future discoveries JH Park, S Wacholder, MH Gail, U Peters, KB Jacobs, SJ Chanock, ... Nature genetics 42 (7), 570-575, 2010 | 770 | 2010 |
NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses M García-Closas, N Malats, D Silverman, M Dosemeci, M Kogevinas, ... The Lancet 366 (9486), 649-659, 2005 | 770 | 2005 |
The carcinogenicity of human papillomavirus types reflects viral evolution M Schiffman, R Herrero, R DeSalle, A Hildesheim, S Wacholder, ... Virology 337 (1), 76-84, 2005 | 762 | 2005 |